History and Evolution: of Patent Law
History and Evolution: of Patent Law
(i) Copyright
(iv) Trademark
d with a com-
History and Evolution
of Patent Law 2
(ii) TS
iv) SM
Chapter objectives
As we have studied the importance of
property plays an important role in the intellectual property rights, we know that this form off
why diferent countries have tecihnological progress of the country. This is the reason
different patent laws. The patent lavs have
changes across the world in the witnessed revolutionary
past several decades. In this
of origin of
patents, evolution of patent laws, Indian chapter will study the concept
we
The Act of 1872 was further amended in 1883 to introduce a provision to protect novelty of the
invention.
In 1888. new legislation was introduced to consolidate and amend the law relating to invention and
designs in conformity with the amendments made in the UK law
The Indian Patents and Designs Act 1911 replaced all the previous Acts. For the first tinme, this Act
brought patent administration under the management of Controller of Patents. The Act was further
amended in 1920 to enter into mutual arrangements with UK and other countries tor securing
priority.
Provisions were made relating to the grant of secret patents, patent of addition, use of invention by
government, powers of the Controller to rectify register of patent and increase of term of the patent.
In 1945. an amendment was made to provide for the filing of provisional specification and submis-
sion of complete specificaticn within 9 months.
In 1949, the Government of lndia constituted a committee under the Chairmanship of Justice
(Dr.) Bakshi Tek Chand, a retired Judge of Lahore High Court, to review the patent rules and regula-
tions in India in order to ensure the implementation of the patent system in the interest of the nation.
History and Evolution of Patent Law 23
C
Co
etween US and n e Committee submitted its interim renort on 4 August 1949 with recommendations for preven-
the foreign ap- ton of misuse of patent right in India and suggested amendments. The committee also observed
that the Patents Act should contain clear indication to ensure that food and medicine and surgical
ry. Switzerland and curative devices are made available to the Dublic at the cheapest price, which should be made
nce in 1857. The Government of India appointed Justice N. Rajagopala Ayyangar Committee to suggesi
unchanged since necessary changes in the patent law. The report was submitted in September 1959 by the Commit-
WS: tee, which comprised of two parts. The first part dealt with general aspects of the Patent Law along
with evils of the patent system and solution with recommendations in regards to the law and the
second part gave detailed note on several clauses ofthe lapsed bills 1953. This report recommend-
s within a speci ed major changes in the law, which formed the basis of the introduction of the Patent Bill 1965.
a
This amended bill introduced in the Lok Sabha 21 September 1965, which, however
was on
lapsed. In 1967, an amended bill was introduced, which was referred to a Joint Parliamentary
Committee and on the final recommendation ofthe Committee, the Patents Act 1970 was passecd.
O This Patent Act 1970 replaced the 1911 Act so far as the patents law was concerned. However, the
cal innovation by
Act 1911 was continued to be applicable to designs. Most ofthe provisions of the 1970 Act were
1g their invention
brought into force on 20 April 1972 with the publication of the Patents Rules, 1972.
The Patents Act 1970 remained in force for about 24 years without any change till December
us legislation was
1994 with further amendments in 1999, 2002, 2005 and 2006.
f their inventions.
hout the approval A brief history of the Indian patent acts is shown in the Table 2.1.
38 of 2002).
Inventions
1883 The Protection of
Act.
The Act was consolidated as the Inventions and Designs 2003 by repi
1888 The salien
enacted
and Designs Act was
1911 The tndian Patents
into force on 20 April 1972 1. Non-p:
1972 The Patents Act (Act 39 of 1970) Ccame
Act 20
1999 came into force on 26 March
1999 The Patents (Amendment) Act, and ca
2003
The Patents (Amendment) Act 2002 came into force from 20 May 2. The te
2002
the da
(Amendment) Act 2005 effective from 1 January 2005
The Patents
2005
factur
of the
any
criteria in case of publication. 3. The
6. There adoption of absolute novelty
was
for opposition to the grant of a patent. to
7. There was an expansion of the grounds communication and
certain categories of prior publication, prior date
8. It illustrated the exemption of
prior use from anticipation. 4. Pro
directions relating to inventions relevant for defence purposes. inf
9. The laws illustrated secrecy
in
of inventions for government purpose, research
or
for the use 5. Pro
10. The law provided provision
struction to pupils. 6. Th
There reduction in the term of process patents regarding the
substances capable of being
11. was 7. In
used as food or as medicine or drugs.
aL
12. There was enlargement of the grounds for revocation of a patent.
an
as grounds for compulsory licences,
13. The law marked the provision for non-working patents 8. 1
licences of right and revocation of patents.
to use an invention for purposes
14. The law included additional powers of the Central government 9
of government including government undertakings.
licence agreements/contract 10
The law had the provision of making restrictive conditions in
as
15.
void for the prevention of abuse of patent rights.
16. The law had the provision for appeal to High Court on certain decisions of the Controler.
11
17. The law had the provision for opening several branches ofthe Patent Office.
18. The patent can be revoked at any point of time in the interest of the public.
History and Evolution of Patent Law 25
endn Amendments to the Patent Act
1970
First Amendment
The Patents Act 1970 remained in force
of 1852. Certain
for about 24 years without any change
a n c e effecting certain changes inthe Act was issued on 31 December 1994, which ceased
tillDecember 1994
14 years. Operate arter six months. Subsequently, another ordinance was issued in 1999. Inis oranancc was
es (making. cOnsequently replaced by the Patents (Amendment) Act 1999 that was brought into
rorce rerospe
ears from date vely fromi January 1995. The amended Act provided for filing the product patent application in the
areas of
pharmaceuticals drugs and agro chemicals, as such patents were not allowed earlier. However,
such applications were to be examined only after 31 December 1994.
Second Ammendment
he second amendnment
to the 1970 Act was made
38 of 2002). This Act came
through the Patents (Amendment) Act 2002 (Act
into force on 20 May 2003 with the introduction of the new Patent Rules,
2003 by replacing the earlier Patents Rules, 1972.
The salient features of the
Patents (Amendnment) Act 2002 were as follows:
.
Non-patentable inventions were further codified. Section 2()G) of Patent
Act 2002 defines the term (Amendment)
"invention' as 'a new product or process involving an inventive step
and capable of industrial
application' where inventive step' means a unique feature.
2. The term of
patent was extended to 20 years for all technologies. This term is calculated from
the date of
filing of the application. Earlier, the term of patent for method or of manu-
process
facture of substance (e.g. food, medicines, drugs etc.) was 5 years from the date of the
of the patent, 7 years from the date of
or
sealing
patent, whichever period is shorter and in respect of
any other invention, 14 years from the date of the patent.
3. The date of
every patent will be the date of filing the application for patent. While,
to The Patent Act
1970, the date of patent was the date of filing of according
nmunication and
date of patent is very complete specification. This
important in order to determine the term of parent.
4. Provisions were made for reversal of
Ice purposes. burden of proof on the defendant, in case of
infringement. process patenis
e, research or in-
5. Provisions were made to issue
compulsory licences in order to meet public health.
6. The provision of licence of right was deleted.
capable of being
7. Introduction of
system of deferred examination. This means the Controller will not
amination of the application. Examination of an initiate ex-
application will now be taken up
only upon re-
pulsory licences,
quest by applicant. The request is to be made within 48 months from the
8. It emphasized on application filing date.
mandatory publication of applications
after 18 months from the date of
ation for purposes
the application. filing
9. It included the
provision for process patent for micro-organisms.
ments/contract as 10. Appellate Board was established. This Appellate Board hears and decides
sion of the Controller. This board is above the appeals of the deci-
Controller in hierarchy and the
e Controller.
the Appeal Board is in Chennai. headquarters of
11. The time for filing the request for restoration
from I year to 18 months.
of the lapsed patent (Section 60) was extended
26 IPR, Biosafety and Biocthics Tabl-
l o w e s t i n t e r n a t i o n a l
** ncorporated the provision for parallel import of patented products at lowest inte S. N
of patented commodity from anywhere in
the w
worla
is the import
prices. Parallel import here. A parallel import is a mechanism
that nelpo
*
Third Amendment
The third amendment to the Patents Act 1970 was introduced through the Patents (Amendment)
Ordinance, 2004 on January 2005. This ordinance was later replaced by the Patents (Amendmen)
Act 2005 on 4 April 2005, which was brought into force from 1 January 2005.
The salient features of the Patents (Amendment) Act 2005 amendment were as follows:
1. It extended the product patents to all the fields of technology including food, drugs, chemicals
and micro-organisms.
2. The provisions relating to exclusive marketing rights (EMRs) were deleted.
3. Introduction of a provision for enabling grant of compulsory licence for export of medicines to
countries which have insufficient or no manufacturing capacity to meet emergent public health
situations.
6
4. It had modification in the provisions relating to opposition procedures having both pre-grant and
post-grant opposition in the Patent Office.
5. Strengthening the provisions relating to national security to guard against patenting abroad of
dual use technologies.
6. Rationalization of provisions relating to timelines with a view to introducing flexibility and
reducing the processing time for patent application.
2 Request for examination to be made within Request for examination to be made within
36 months 48 months from date of priority or from date of
from date of priority or from date
(Amendment) of fting application filing application.
s (Amendment) 3 The first examination report has to be worked The first examination report has to be worked
out within 6 months from the date of issue of out within 12 months from the date of issue of
ows: the report the report.
rugs, chemicals A A pre-grant opposition to be filed within A pre-grant opposition to be filed within
3 months from the date of publication for the 6 months from the date of publication of the
application or before the grant of patent. application or before the grant of patent.
of medicines to Reply to pre-grant opposition to be filed within Reply to pre-grant opposition to be filed within
ent public health 1 month from date of notice of opposition. 3 months from date of notice of opposition.
th pre-grant and
6
official fees to be paid in ash or bank draft or official fees can also be paid electronically.
cheque.
3 months were required by the controller to
enting abroad of 21 days were required by the controller to grant
grant the permission for filing the patent the permission for filing the patent abroad
abroad from the date of request. from the date of request.
ig flexibility and
sal of patent ap- Changes have also been made to make the patent rules
user-friendly.
Dfices. 1. The
i
plication is to be
ement of certainty
imelines available
INTERNATIONALCONVENTIONS AND TREATIES
India is a member of World Intellectual Property Organization (WIPO), an international organiza-
tion responsible for the promotion and protection of intellectual property throughout the world. With
respect to patents, India is a member of several international
organizations and treaties as follows:
World Intellectual Property Organization (WIPO)
a World Trade Organization (WTO) with efect from 1 January 1995
12 months. a Paris Convention (for the protection of industrial property) with effect from 7 December1998
28
IPR, Biosafety and BioethiCs
Pat
t Cooperation Treaty (PCT) with effect from 7 December 1998
National treatment
a Parallel importation
Right of priority
Independence of patents
Protection against false indication and unfair competition.
However, the main objective of the convention is to give protection for obtaining, maintaining and
enforcing the industrial property of the member nations. The member nations of the Paris Convention
have the advantages that they alone can be the members-of various
international conventions and trea-
ties such as the following:
O Patent Cooperation Treaty (PCT for centralized international application procedure for grant of
patent at national as well as regional level)
Budapest Treaty (Deposit treaty)
oUPOV (Union for Protection of New Varieties of
Plants)
Madrid Agreement (for repression of false or
deceptive indications of source on goods)
Madrid Protocol (regarding registration
of marks)
Hague Agreement (concerning deposit of industrial designs).
In
1886, copyright entered the international arena, with Berne Convention the protection of
literary and artistic works. Like the Paris Convention, the Berne Convention setforup an international
bureau to carry out administrative tasks.
In 1893,
these two small bureaus united to form an international organization called the United
International Bureaux (BIPRI, French
acronym) for the protection of intellectual property with a
af of s History and Evolution of
Patent Law 29
n, memb Sta
T04
Or seven people, which was the oredccessor of WIPO.
member states, i.e. over 90% of the countries of the world are
1ater on, undergoing structural and adiaistrative reforms. In 1974,
Today WIPO is
its members.
a dynamic entity
B l R I Decame
WIPO became a specialized
with
WIPO
4gny the United Nations system of organization with a view to administer intellectual property
matters recognized by the member states of the United Nations and expended its role. Through its
United Nations member state and secretariat, WIPO seeks to
roperty are pro-
or their ingenu- provide services for international application for industri. property rights,
th the legal and exchange intellectual property information among member countries,
and
provide legal and technical assistance to developing and other countries
nvention for the resolve the private disputes on intellectual property and harmonizes theintellectual property (IP)
lp the inventors laws and procedures.
e Paris Conven- WIPO was established by the convention of 14 July 1967, which entered into force in 1970. Since
n 1834. It set up 1974, it has been a specialized agency administering a number ofinternational unions or treatiesin
llows the grant- the area of intellectual property like Paris and Berne Conventions.
omotion among WIPO undertakes development cooperation for developing countries through advicé, training and
I patents, utility furnishing of documents. A similar agreement on cooperation between WIPO and WTO came into
1 and repression force on 1 January 1996. The agreement provides cooperation in the following areas
dustrial patents
ch is recognized Technical knowledge
Notification of and access to national laws and regulation
Translation of national laws
Implementation of procedures for the protection of national emblems.
The agreement between WIPO and WTO was concluded in December 1995. It provides assis-
tance for legal and technical matters to the developing countries related to TRIPs agreement. Till
date more than 134 countries have received its advice. WIPO's advice takes into account different
situations in every country, given that member states have diferent legal systems and different
political and cultural structures. In order to strengthen the TRIPs implementation process, during
maintaining and the last four years, WIPO has promoted the interaction among different stakeholders at the nationa
aris Convention level to include, for example, officials of law reform commissions, chambers of commerce and fed-
entions and trea- eration of industries, research and development institutions, parliamentarians, high-level officials
of ministers of trade, agriculture, health, science and technology, culture, justice, environment and
dure for grant of others.
r 8 months, with
their obligations. Each country receives guarantees thatits exports will be treated fairly and consis-
tently in othercountries' markets.SumeTutesapply for theimports intOitS market.The system also
Scovering a new
gives developing countries some flexibility inimplementingtheircommitments.
WTO has several benefits like the system helps in promoting
peace, helps in dispute settlement,
the participation
makes rules that make life easier for all, conducts freer trade that cuts the costs of living,provides
are shielded from
during 1960-62.
more chorce of products andqualities, incomethatis due israisedand governments
of state, Douglas
lobbying. Moreover, the system encourages good government.
in it, resulting in
More specifically,its main objective is to help trade fHow smoothly, freely, fairlyand predictably
at the internationallevel. Internationaltrade is beneficialtoallthecountries and their citizens. It isa
to the creation of factthat trade leads to growth, which in turn promotes national development and reduces poverty. The
7. With 62 coun-
foowingare its activities:
o Negotiation to reduce or eradicate hindrances in trade («.g. import tariffs and other barriers to
orld trade. It also
sed in the context trade) and agreeing on rules that govern the conduct of internal trade (anti-dumping. subsidies,
ther country t a product standards etc.)
nnot be explained o Administrating and monitoring the application of WTO trade agreement rules in goods, trade in
than 'fair value' services, IPR
It causes or threat- Reviewing the trade-related policies of WTO members as well as ensuring transparency in re-
gional and bilateral trade agreement
with the participa- o Settling disputes among its members regarding interpretation and application of the trade agreement
and 'framework g Educating public about WTO, its mission and its activities
illion. Conducting economicresearch
under WTO: Assisting the accession (process ofbecoming a member) of some 20 non-member countries
Building capacity of developing country government officials in international trade matters
Assisting developing countries in trade policy issues, through technical assistance and training
programmes
32
IPR Biosafety and Bioethics
IPR,
WTO Treaties
The following treaties are enforced by the WT0:
General Agreement on Tariffs and Trade (GATT)
General Agreement on Trade and Services (GATS)
Agreement on Technical Barriers to Trade (TBT)
Agreement on Government Procurement (AGP)
Agreement on the Application of Sanitary and Phytosanitary Measures (SPS)
9Agreement on Trade-Related Aspects of Intellectual Property Rights (TRIPS)
O Agreement on Trade-Related Investment Measures STRIMs)
Agreement on Agriculture (A0A)
Doha Round
In November 2001, divergences between developing and
the declaration on the TRIPs Agreement and developed countries led to acompromise on
round of trade public
health. It was the Doha Round, which is the latest
negotiations among WTO members in which 142 countries participated and the aim
the
of the round is to achieve
major reform of the international trading system through the introduction
of lower trade barriers and revised trade rules. This was the joint effort of India, Brazil and 55 African
countries and all the 142 countries
measures in order to
supported the view that governments are free
to take all necessary
protect the public health. WTO accepted the view that patents should not hinder
the public health
protection. Public health WTO's priority;, this was a boon to India. It covered about
21 areas of trade. The round is also known
fundamental objective was to improve the
semi-officially as the Doha Development Agenda as its
areas were covered in the round:
trading prospects of developing countries. The following
1.
Implementation-related issues and concerns
2. Agriculture
3. Services
4. Market access (for non-agriculture products)
5. Intellectual property: trade-related aspects . .
615. E
13. Dispute settlement
d and their
4Trade and environment
Sma 5. E-commerce
tad Trad
16. Small economies
The TRIPs agreement extended its protection scope to such technological areas as pharmaceutica
products and computer software, which were previously unprotected in many countries. The gener
t
a Application of basic principles of the trading system and other international intellectual prop
agreements.
a Methods used for the adequate protection of intellectual property rights.
34 IPR, Biosafety and Bioethics
The obligations under the agreement apply equally to all member countries, but developing
countries will have a longer period to face them. Special transition arrangements operate in the
situation where a developing country does not presently provide product patent protection in
gintroduced.
the area of pharmaceuticals.
Patents are very important regarding drugs and pharmaceutical industry. The reasons for the impor-
d by the TRIPs
tance of patents in the pharmaceutical industry are as follows:
Is to be provided
mely the subject The costs of pharmaceutical R&D are high.
those rights, and There is a disclosure requirement, at the time ofregistration.
s, but it also says Imitation in this area is relatively easy; therefore, the patent is essential to protect the original
tent necessary to invention.
unjustifiably dis- Phamaceutical patents allow the company to make extra profits due to the monopoly rights which
ber countries are the patent confers. The company can charge a higher price and earn more than would have been
if they do so, the possible in case of free competition.
rs may uSe mea- From these profits, R&D costs
mant still allows
can be recovered.
lt the measure of TRIPs Principles
ingrountry, then The TRIPs
i met
ods. Agreement has a major role to play in harmonization of the norms and standards of intel-
tin lectual property protection. It requires members to comply with a defined set of minimum standards
lude in their
for the protection of intellectual
property rights covered in it.
Its basic principles are as follows:
ons that are new,
a It makes it compulsory for the member countries to provide patents for products and processes in
cation (or useful)
all fields of
technology, subject to the tests of novelty, inventiveness and industrial use.
I t mandates patenting
otect their rights of 'micro-organisms', and microbiological and non-biological
processes.
The members are
allowed to make only limited exclusions from patentability. The exclusions are
allowed on the grounds of public order or morality, or
inrespect protection extended to human,
of
ated in patent leg- animal and plant life or health.
RIPs Agreement. a It also gives option to the states for protecting new plant varieties through patents or
effective sui generis system. , through the
are not enough,
a It ensures that the
ds or procedures protection and enforcement of intellectual property rights should contribute
to the promotion of
n certain general technological innovation for the mutual advantage of producers and users of
ins provisions on technological knowledge and in a manner conducive to social and economic welfare.
inal procedures,
Major Changes in Indian Patent System Post-TRIPs
infringement are
must be fair and Before the TRIPs Agreement, pharmaceutical patents and other intellectual property rights on drugs
Des in detail how were not
recognized in many developing countries (unlike many industrial countries). There were
no international standards for
sional measures, patent protection; countries had varied regulations on IP
ht, under certain depending on their own needs. In the pharmaceutical sector, some 40 countries did not protection
protection for phärimaceutical pröducts. Patents were simply not available for provide patent
tions in these countries, which pharmaceutical inven-
implied that no one could claim an intellectual property right on such
respect of TRIPs products. As a result, copies of medicines protected by a patent in other countries were
list of issues that able, usually at a lower price than the original patented widely avail-
ays to describe an local companies or imported, without
drug. The copies were either manufactured
by
having to ask the patent holders' permission. This practice has
oroadly classified now come to an end.
Copies of patented drugs will remain on the market but it will no
sible to manufacture and market copies of new patented medicines in those longer be pos-
40 countries, unless the
36 IPR, Biosafety and Biocthics
Table 2.3 Patent Laws Post-TRIPs
Agreement
Changes in lndian
Patent Amendment Act
S. No. Indian Patent Act 1970 TRIPs Agreement
or drugs years
Conforms to TRIPS requirement
2 Term of patent: 14 years; in
case of chemicals and drugs,
Term of patent: 20 years
(Patent Act 1999) patem
5 to 7 years patent Ca
3 Limited compulsory licensing, Conforms to TRIPS requirement tional apy
Compulsory licensing and signed on
licensing of drugs no ficense of right was furthe
4 Several areas were excluded Almost all fields of technology Uses the exceptions allowed by The trea
TRIPS. Rejects the patents on
from patents like the method are patentable. Plant varieties countries
of agriculture, surgical or ther- and some areas of agricul living things, non-living sub- Internatio
stances ocCurring in nature,
apeutic methods of treating ture and biotechnology are
plants and animals
major incri
humans, animals or plants in excluded from patentability
order to increase the economic internat
PCT.PsA
value of products pe
office is t
Government allowed to use Very limited scope for Conforms to TRIPS requirement entitled to f
patented invention to prevent governments to use patented for US appl
Scarcity inventions an internati-
An India
1. He ca
original manufacturer has chosen not to seek any patent protection there. Table 2.3 differentiates the
changes in the patent law after the introduction of TRIPs in 1995. filing
Under the TRIPs Agreement, all WTO members are required to make patents available for phar- filing
maceutical and biological inventions in their countries. Article 27.3(b) of TRIPs Agreement gives Paten
its members some freedom to exclude plants, animals and 'essentially biological processes from from
patentability as genetically modified organisms and GM foods had created fears and uncertainty of its 39 frc
impact on health and the environment and have raised important ethical issues in diferent countries. 2. The a
However, it also states that micro-organisms and non-biological and micro-biological processes have missi
to be patentable. The wording is deliberately ambiguous, in order to give countries some freedom to filed
interpret this in their national legislation as they consider fit. Indiar
The TRIPs Agreement requires the WTO member states to introduce patent protection only to the da
products that were invented after 1 January 1995, i.e. products for which a patent application has been
The pate
filed in a WTO member state after 1995. This means that, in accordance with TRIPs, products already
on the market cannot be given patent protection, because if they are already marketed, they are not
internationa
is carried ou
new, and so do not meet the TRIPs conditions necessary to grant a patent. Therefore, only new drugs
or new indications, formulations or processes invented after 1995 are patentable in all WTO member SearchingA
by the ISA
countries, or before a year, if priority is claimed. ing the pate
The developing and least-developed countries not granting drug patents must have a system, often
referred to as a 'mail-box' system, to store patent applications as from 1995 until the transitional pe is based on
riod expires. At this time, the various patent applications waiting in the 'mail-box' will be examined Internationa.
which starts from the filing date, will Paris Co
according to the TRIPs standards and, if granted, the patent term, members. P
last fo
ronpeembe
History and Evolution of
last for 20 years. 1The
Patent Law 37
member countries have to meet some
member countries may minimum standards; however,
go for
Act Europe and the United
States,
greater IP protection than required in the Agreement. For
some WTO
example,
5 years, to pharmaceutical patents
may be extended beyond 20 years,
in
on of TRIPs compensate for the long delays
in obtaining marketing for up to
atent Bil extensions vary from country to approval for a drug. Such patent
country since there is absence of international
on the date of
marketing approval. However, the standards, depending
pharmaceuticad
patent cannot be extended
approval in European countries, and 14 years in the Unitedbeyond
years from the date of marketing 15
States.
requirement Patent Cooperation Treaty
Patent Cooperation Treaty
(PCT) is administered by WIPO, which gives rise to 'centralized
requirement
tional application
procedure' for the grant of patent at national and regional levels. The interna-
signed on 19 June 1970 at Washington, amended on 28 treaty was
was further modified on 3
September 1979 and on 3 February 1984. It
October 2001.
is allowed by The treaty makes it
possible to seek patent protection for an invention simultaneously in
patents on countries. The total number of PCT many
-living sub contracting states as on 7 September 2012 is 146 (also known as
International Patent Cooperation
in nature, Union). A majority of countries are signatories of the PCT including
major industrialized countries like Argentina and Taiwan.
als PCT application can be filed
by anyone who is a national resident of the contracting state. An
international patent application (PTC
office is the branch of PCT where the
application) is filed at the receiving office (RO). The receiving
patent applications are filed. Nationals and residents of India are
irequirement entitled to file international applications for
patents under PCT at Patent Receiving Office, Delhi while
for US applicants, the branch office is US patent office. Applicant from any contracting state may file
an international patent application at the International Bureau in Geneva.
An Indian applicant can file a PCT international application in the following manner
1. He can file the application in the Indian Patent Office, which acts as the Receiving Office. Afier
erentiates the
filing a patent application-in India, anytime before the expiry of 12 months from the date of
filing, an international application can be filed in International Bureau of WIPO or in Indian
able for phar- Patent Office as Receiving Office. However, if the international filing is done within 6 weeks
eement gives from the date of filing in India, this can be done only after taking the permission under Section
ocesses from 39 from the Indian Patent Office.
ertainty of its 2. The application can also be filed directly in the International Bureau of WIPO after taking per-
ent countries. mission under Section 39 from the Indian Patent Office, claiming the priority of the previously
rocesses have certified copy of the
filed Indian patent application along with the prescribed application fee. A
ne freedom to within 16 months from
Indian patent application may be filed with the international application
the date of priority.
2ction only to
applicant
inventor the desires. In such cases.
application can be withdrawn if the
or
ation has been The patent
PCT makes an international patent search and the search
ducts already international publication will not tak place.
an International
of the major patent offices appointed by the PCT assembly as
1 they are not is carried out by one
written opinion are communicated
Authority (ISÄ). The international search report and the
nly new drugs Searching it helps in the process of fil-
to the applicant. PCT
does not issue the patent directly but
by the ISA examination
WTO member and cost-eflective manner. The
countries in the most efficient of the
ing the patent foreign
in
is made by the most competent people
international search report and
System, often is based on preliminary
Examination Authority. to its
ransitional pe- International Preliminary conventions and treaties exclusively
number of international deposit of
1beexamined Paris Convention opens a conventions apart from Budapest Treaty
(for
members. PCT is one of
the international
iling date, will
38 IPR, Biosafety and BioethicS (for repres-
Madrid Agreement
varieties of plant),
the protection of new Madrid Protocol
(concerning depositof
d 8nism), UPOV (for goods) and
indication ofsource on
Ofalse or decetive disc
industrial design). and
Procedure search report
between4 dise
International Searching
Authority, PCT issues
a
The first person to have filed the application will The first person to invent will get the patent. This
get the patent. Filing date is important. usually involves examining laboratory logbooks,
establishing dates for prototypes, and so on.
of patent to if the person who filed later is found to have
any new and invented earlier, he may be awarded the patent.
cess of manufac- if the invention has become publicly available in There is a one-year grace period (35 US Code
rany new and 2
any way, by the inventor or anyone else, before Section 102), which means that the inventor can
ng invention freely publish his invention without losing patent
the filing of patent application, the application
energy are will be rejected (Article 54 EPC). rights. This only applies for the United States.
Any one way of practicing the invention must be us patent law requires the inventor to include
and novel in included in the application (Article 83 EPC), but the best way to practice the invention in the
or novel design it is not compulsory to state that this way is the patent application (35 US Code Section 112).
best way, or a good way.
ents of compo
All patent applications are published 18 months Now in the United states, patent applications
after their filing date, unless they have been are published 18 months after their filing date,
some utility
withdrawn. unless they have been withdrawn or they are
filed with a non-publication request, stating ti
'first-to-invent the application is for United states only (Earlier
ould maintain
the patents were published only after grant)
of invention.
The European Patent Convention is a treaty A US patent right is enforceable in the whole
5
1 of post-grant signed by 27 European countries. Patents under territory of the United states. It aliows the
the EPC are granted by the European Patent patent holder to prevent anyone from making.
ited States office (EPO) in Munich. using or selling the patented invention in the
nited States United States as the US patent law (35 US Code)
is a federal statute.
ries can also 6 The two most important patentable require- US requirement that the invention must be
ments in European patent law are that, an novel and must be non-obvious (35 US Code
invention must be novel and involve an inventive Sections 102 and 103)
t sheet with step (Article 52 EPC). It clarifies that the inven-
n, assignees, tion has an inventive step if it solves a technical
it drawing of the problem ina non-obvious way, which further
introduces two extra requirements: it must solve
is invention, he a problem (no problem solved means no inven-
patent till one tive step), and that problem must be technical
excludes solving economicproblems).
(continued)
42 IPR, Biosafetr and Biocthics Tabtk
S. No.
Table 2.5 (Continued US Patent Act will
patents)
(and
S. No. European Patent Act applications
US p a t e n t one-part claim
have any-
typically where
7 turopean patents and applications
contain two-part claims.
almost always
r e - e x a m i n a t i o n
procedure
to the
the y
(Virtually always) It has a and
evidence
a granted The iv
8 the validity of e n g a g e s
one can
in 1909.ABthePatent Act was replaced by the Patent Law of 1899, which was completeiyrev
Japanese e Meiji era, the Patent Act was completely revised twice, in 1921 and 1959. T hus, the
ings, the was amended several times in 1959, especially regarding the opposition proceed-
O patent, and compliance with the Patent Cooperation Treaty (PCT) in relation the
novelty criteria.
Table 2.7 differentiates
betwecn Japanese and US patent laws.
Table 2.7
Differences between Japanese and US Patent Laws
S. No.
Japanese Patent Law
United States Patent Law
Japan foliows first-to-file system. USfoltow first-to-invent system.
An examination will be carried out
the application only for Applications are examined in the order they
for which the applicant or a were filed, unless the
third party has US Patent Office finds a
fileda request for examination
(within 3 years) and paid the examination compelling reason to do otherwise
fees
3 An
application can consist of more than one A
claim. There is no patent application can have only one claimed
surcharge for multiple de-
pendent claims. However, invention. if the examiner determines
when filing that there
for examination, the
a
request is more than one claimed invention in the ap-
based the number
official fee is calculated plication, he will
on
of claims the application to
request the inventor to restrict
only one claim.
An unusual feature of the
Japanese patent sys- Aplications are examined
tem is that in the order
applications are not automatically were filed automatically. they
examined. The applicant has 7
years from the
filing date to file a request for examination.
5 Recentchanges to japanese patent law in 1996 There is
included the move from a re-examination procedure, where
a
pre-grant patent anyone can
present reasons and evidence to the
opposition system (3 months to file opposition) USPTO to challenge the
to a
post-grant oppósition system (6 months validity of a granted pat-
ent. It does not work the
to file opposition, but the same as an
patent is valid until opposition.
declared otherwise)
tion in the ap- General (GG) and the standards for the
of the Governor 2006. lectual property. It provides
entor to restrict several amendments till property rights
and
went through full range of intellectual
not found in the
m.
provisions which were
of those standards both
The
follows: also the enforcement administra-
Indian Patent Act
1970 are as
legal and
e order they internally and through
be extended by
T h e term of patent could not tive actions. PCT is a treaty
administered